COVID-19: Physiopathology and Targets for Therapeutic Intervention

被引:5
作者
de Almeida, Juliana O. [1 ]
de Oliveira, Victoria Regina T. [1 ]
Avelar, Joao Lucas dos S. [1 ]
Moita, Bruna Simoes [1 ]
Lima, Lidia Moreira [1 ]
机构
[1] Univ Fed Rio de Janeiro, Lab Avaliacao & Sintese Subst Bioat, Av Pedro Calmon 550,CP 68024,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil
关键词
COVID-19; SARS-CoV-2; molecular targets; spike protein; proteases; PAPAIN-LIKE PROTEASES; DROMEDARY CAMELS; SPIKE PROTEIN; SARS-COV; CORONAVIRUS; DRUG; INFECTION; SYSTEM; ACE2; IDENTIFICATION;
D O I
10.21577/1984-6835.20200115
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The pandemic status of COVID-19 was recorded by the World Health Organization (WHO) on March 11, 2020. Since then, more than 10 million cases have been confirmed worldwide, with more than 500,000 reported deaths. Throughout this period, efforts by the global scientific community have focused on understanding the disease process and searching on preventive (e.g. vaccines) or therapeutic (e.g. drugs) alternatives of treatment for COVID-19. The present review portrays the historical aspects associated with the discovery of SARS-CoV-2, the etiological agent of COVID-19, describes the pathophysiological aspects of the disease, the viral replication process and discusses the main molecular targets subject to therapeutic intervention, aiming the design, discovery and development of new drugs to treat COVID-19.
引用
收藏
页码:1464 / 1497
页数:34
相关论文
共 31 条
[1]   2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruciality of Furin and relevance with cancer [J].
Afsar, Cigdem Usul .
MEDICAL HYPOTHESES, 2020, 140
[2]   The proximal origin of SARS-CoV-2 [J].
Andersen, Kristian G. ;
Rambaut, Andrew ;
Lipkin, W. Ian ;
Holmes, Edward C. ;
Garry, Robert F. .
NATURE MEDICINE, 2020, 26 (04) :450-452
[3]  
Carriere F., 2020, BIOCHIMIE
[4]  
Chandwani Ashish, 2008, Ther Clin Risk Manag, V4, P1023
[5]   Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor [J].
Chen, Xiangyu ;
Li, Ren ;
Pan, Zhiwei ;
Qian, Chunfang ;
Yang, Yang ;
You, Renrong ;
Zhao, Jing ;
Liu, Pinghuang ;
Gao, Leiqiong ;
Li, Zhirong ;
Huang, Qizhao ;
Xu, Lifan ;
Tang, Jianfang ;
Tian, Qin ;
Yao, Wei ;
Hu, Li ;
Yan, Xiaofeng ;
Zhou, Xinyuan ;
Wu, Yuzhang ;
Deng, Kai ;
Zhang, Zheng ;
Qian, Zhaohui ;
Chen, Yaokai ;
Ye, Lilin .
CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (06) :647-649
[6]   Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection [J].
Cheng, Vincent C. C. ;
Lau, Susanna K. P. ;
Woo, Patrick C. Y. ;
Yuen, Kwok Yung .
CLINICAL MICROBIOLOGY REVIEWS, 2007, 20 (04) :660-+
[7]   Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19 [J].
Chu, Hin ;
Chan, Jasper Fuk-Woo ;
Wang, Yixin ;
Yuen, Terrence Tsz-Tai ;
Chai, Yue ;
Hou, Yuxin ;
Shuai, Huiping ;
Yang, Dong ;
Hu, Binjie ;
Huang, Xiner ;
Zhang, Xi ;
Cai, Jian-Piao ;
Zhou, Jie ;
Yuan, Shuofeng ;
Kok, Kin-Hang ;
To, Kelvin Kai-Wang ;
Chan, Ivy Hau-Yee ;
Zhang, Anna Jinxia ;
Sit, Ko-Yung ;
Au, Wing-Kuk ;
Yuen, Kwok-Yung .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (06) :1400-1409
[8]  
Drak Alsibai K., 2020, Medical Hypotheses, P143
[9]  
Hoffmann Markus, 2021, EBioMedicine, V65, P103255, DOI [10.1101/2020.08.05.237651, 10.1016/j.ebiom.2021.103255]
[10]   The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients [J].
Li, Yan-Chao ;
Bai, Wan-Zhu ;
Hashikawa, Tsutomu .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (06) :552-555